Clinical Trial Update: Adebrelimab Combined With Carboplatin and Albumin-bound Taxanol in the Treatment of Resectable Locally Advanced Oral Squamous Cell Carcinoma Cardiac, Randomized, Phase II Exploratory Study [Phase 2]

View source ↗

Summary

Phase II exploratory randomized neoadjuvant trial evaluating adebrelimab in combination with carboplatin and nab-paclitaxel for resectable locally advanced oral…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Oral Squamous Cell Carcinoma (OSCC), Neoadjuvant Chemoimmunotherapy | Phase 2 | Status: NOT_YET_RECRUITING